Clinical trial
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian…
NCT00127920 · Gynecologic Oncology Associates, Other · Completed
Key facts
| NCT number | NCT00127920 |
|---|---|
| Title | Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients |
| Official title | A Phase II, Open-Label, Non-Randomized, Multi-Center Pilot Study of Intravenous Taxol, Carboplatin, Bevacizumab Given Every 21 Days in Patients With Newly Diagnosed Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer |
| Lead sponsor | Gynecologic Oncology Associates, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Neoplasms |
| Intervention type | Drug |
| Interventions | Avastin |
| Enrollment | 20 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Oct 1, 2012 |
| First posted | Aug 9, 2005 |
| Last update posted | Mar 10, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: